Clinical trials for Chromophobe renal cell carcinoma
37 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07485114Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 InhibitorsDaniel Keizman
- RECRUITINGPhase 3NCT07227402A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)Merck Sharp & Dohme LLC · PI: Medical Director
- RECRUITINGPhase 2NCT07233252Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic CancerTianjin Medical University Second Hospital · PI: Hailong Hu, PhD
- RECRUITINGN/ANCT07171190Targeted Abdominal CT in Conjunction With Lung Cancer ScreeningUniversity of Cambridge
- RECRUITINGPhase 2NCT07050771Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer SurgeryThe Methodist Hospital Research Institute · PI: Nestor Esnaola, M.D.
- RECRUITINGPhase 2NCT06642220Ablative Radioembolization of Renal Cell Carcinoma TrialDerek W. Cool
- RECRUITINGNCT06889974Timing of Renal Replacement Therapy Initiation in Tumor Lysis SyndromeUniversity Hospital, Bordeaux
- ENROLLING BY INVITATIONNCT07307157Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only ReviewHarvard Medical School (HMS and HSDM) · PI: Kun-Hsing Yu, MD, PhD
- RECRUITINGN/ANCT06722807ClAmpless, Sutureless PartIAl Nephrectomy for Renal MassesUniversity of Florida · PI: Padraic O'Malley, MD
- RECRUITINGN/ANCT06868186A Multicenter Study of RUS NEHutom Corp · PI: Cheryn Song, M.D.,Ph.D.
- RECRUITINGN/ANCT06965192Designing Visual Tools to Enhance Cancer Surgeon Decision-makingUNC Lineberger Comprehensive Cancer Center · PI: Hung-Jui Tan, MD
- RECRUITINGN/ANCT06829719TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney TransplantationHospices Civils de Lyon
- RECRUITINGPhase 2NCT06601296Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney CancerUniversity of Texas Southwestern Medical Center · PI: RAQUIBUL HANNAN, MD
- RECRUITINGEarly Phase 1NCT06318871Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial CarcinomaDana-Farber Cancer Institute · PI: Wenxin Xu, MD
- RECRUITINGN/ANCT06424080Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.Menoufia University · PI: hossam elsayed kandeel, MSC
- RECRUITINGN/ANCT06290427Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)Azienda Ospedaliera Universitaria Integrata Verona · PI: Alessandro AA Antonelli, MD
- RECRUITINGNCT06327178Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.Nanfang Hospital, Southern Medical University
- ACTIVE NOT RECRUITINGPhase 3NCT05863351Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR StudyECOG-ACRIN Cancer Research Group · PI: Raquibul Hannan
- ACTIVE NOT RECRUITINGN/ANCT06846112Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without RenorrhaphyRegina Elena Cancer Institute · PI: Aldo Brassetti, Doctor
- ACTIVE NOT RECRUITINGPhase 2NCT05805501A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell CarcinomaHoffmann-La Roche · PI: Clinical Trials
- ACTIVE NOT RECRUITINGNCT05887245Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial NephrectomyCentre of Postgraduate Medical Education · PI: Sławomir Poletajew, Prof.
- ACTIVE NOT RECRUITINGNCT05817604Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)Consorci Sanitari de Terrassa · PI: Manuel Galdeano-Rubio, MD
- RECRUITINGPhase 2NCT05641935Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablationjohn eisenbrey
- RECRUITINGNCT06899789Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitisFondazione IRCCS Policlinico San Matteo di Pavia
- ACTIVE NOT RECRUITINGPhase 3NCT04586231A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)Merck Sharp & Dohme LLC · PI: Medical Director
- ACTIVE NOT RECRUITINGPhase 2NCT04071223Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyNational Cancer Institute (NCI) · PI: Rana R McKay
- RECRUITINGPhase 2NCT04322955CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase InhibitionMark Stein · PI: Mark N Stein, MD
- ACTIVE NOT RECRUITINGPhase 3NCT04195750A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)Merck Sharp & Dohme LLC · PI: Medical Director
- RECRUITINGN/ANCT04623502An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or BiopsyUniversity of Texas Southwestern Medical Center · PI: Vitaly Margulis, MD
- RECRUITINGPhase 2NCT06889649SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCCPeking University First Hospital
- ACTIVE NOT RECRUITINGPhase 2NCT03635892A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell CarcinomaMemorial Sloan Kettering Cancer Center · PI: Darren Feldman, MD
- ACTIVE NOT RECRUITINGNCT03630536TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research InitiativeChildren's Hospital Medical Center, Cincinnati · PI: Katherine Somers, MD
- ACTIVE NOT RECRUITINGNCT06339138Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE StudyMayo Clinic · PI: John B. Kisiel, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03541902Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell CarcinomaM.D. Anderson Cancer Center · PI: Matthew T Campbell
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03172754Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell CarcinomaFox Chase Cancer Center
- RECRUITINGPHASE1, PHASE2NCT03093688Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid TumorShanghai Public Health Clinical Center · PI: Qing J Xu, M.D. Ph.D
- RECRUITINGN/ANCT03804320Protocol Active Surveillance Small Renal Masses (SRMs)IRCCS San Raffaele · PI: Roberto Bertini